| アイテムタイプ |
itemtype_ver1(1) |
| 公開日 |
2024-11-27 |
| タイトル |
|
|
タイトル |
Risk-adapted stereotactic body radiation therapy delivered in four fractions in patients with non-small cell lung cancer |
|
言語 |
en |
| 著者 |
Masuoka, Yutaka
Tada, Takuhito
Matsuda, Shogo
Hasegawa, Yoshikazu
Ishii, Kentaro
Inokuchi, Haruo
Shibuya, Keiko
|
| アクセス権 |
|
|
アクセス権 |
open access |
|
アクセス権URI |
http://purl.org/coar/access_right/c_abf2 |
| 権利 |
|
|
権利情報Resource |
http://creativecommons.org/licenses/by-nc-nd/4.0/ |
|
権利情報 |
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International |
|
言語 |
en |
| キーワード |
|
|
主題Scheme |
Other |
|
主題 |
lung cancer |
| キーワード |
|
|
主題Scheme |
Other |
|
主題 |
risk adapted |
| キーワード |
|
|
主題Scheme |
Other |
|
主題 |
stereotactic body radiation therapy |
| 内容記述 |
|
|
内容記述タイプ |
Abstract |
|
内容記述 |
Risk-adapted stereotactic body radiation therapy is preferred over conventional radiotherapy at the authors’ institution based on the hypothesis that even with a lower than recommended dose, stereotactic body radiation therapy would yield better local control than conventional radiotherapy. This retrospective study was performed to verify the hypothesis. Data from 34 patients with non-small cell lung cancer, who underwent risk-adapted stereotactic body radiation therapy delivered in 4 fractions between 2012 and 2018, were analyzed. The 3-year local control rate for patients receiving 42–44 Gy, 40 Gy, and 32–38 Gy was 80.8%, 75.0%, and 66.7%, respectively. The 3-year overall survival rate was 63.5%, 63.5%, and 40.0%, respectively. Three patients experienced grade 3 toxicities, with no toxicities > grade 3 observed. The results support the use of risk-adapted stereotactic body radiation therapy, both with a relatively high dose and a low dose. |
|
言語 |
en |
| 出版者 |
|
|
出版者 |
Nagoya University Graduate School of Medicine, School of Medicine |
|
言語 |
en |
| 言語 |
|
|
言語 |
eng |
| 資源タイプ |
|
|
資源タイプresource |
http://purl.org/coar/resource_type/c_6501 |
|
タイプ |
departmental bulletin paper |
| 出版タイプ |
|
|
出版タイプ |
VoR |
|
出版タイプResource |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| ID登録 |
|
|
ID登録 |
10.18999/nagjms.86.4.588 |
|
ID登録タイプ |
JaLC |
| 関連情報 |
|
|
関連タイプ |
isVersionOf |
|
|
識別子タイプ |
URI |
|
|
関連識別子 |
https://www.med.nagoya-u.ac.jp/medlib/nagoya_j_med_sci/864.html |
| 収録物識別子 |
|
|
収録物識別子タイプ |
PISSN |
|
収録物識別子 |
0027-7622 |
| 収録物識別子 |
|
|
収録物識別子タイプ |
EISSN |
|
収録物識別子 |
2186-3326 |
| 書誌情報 |
en : Nagoya Journal of Medical Science
巻 86,
号 4,
p. 588-595,
発行日 2024-11
|
05_Masuoka.pdf (545.9 KB)
.png)
